Company Overview - Church & Dwight Co., Inc. (CHD) is valued at a market cap of $23.1 billion and is based in Ewing, New Jersey, focusing on household, personal care, and specialty products [1] - CHD is classified as a "large-cap stock" due to its market cap exceeding $10 billion, highlighting its size and influence in the household & personal products industry [2] Business Model and Brand Portfolio - The company employs a unique "Evergreen" business model that balances value-tier products with premium innovation [2] - CHD has a strong portfolio of brands, including Arm & Hammer, OxiClean, Trojan, and Batiste, which dominate their categories through high consumer trust and low private-label exposure [2] Stock Performance - Currently, CHD is trading 14.2% below its 52-week high of $113.91, reached on April 4, 2025, while shares have gained 15.5% over the past three months, outperforming the S&P 500 Index's 2.9% drop [3] - Year-to-date, CHD shares are up 16.6%, compared to the S&P 500's 3.1% decline, but have fallen 10.9% over the past 52 weeks, lagging behind the S&P 500's 20.1% increase [5] Recent Earnings and Projections - Following its Q4 earnings release, CHD shares climbed 4.7%, reporting an adjusted EPS of $0.86, which exceeded expectations due to steady demand for both value-oriented and premium products [7] - The company’s adjusted gross margin expanded by 90 basis points to 45.5%, with management projecting an additional 100 basis points of margin expansion in 2026 [7] - CHD guided for organic sales growth of 3% to 4% driven by volume, and adjusted EPS growth of 5% to 8% for 2026 [7] Competitive Position - CHD has slightly underperformed its rival, The Procter & Gamble Company (PG), which fell 10.1% over the past 52 weeks, but has outpaced PG's 5.4% year-to-date rise [8]

Group 1: Procter & Gamble (PG) Digital Strategy - Digital retail and e-commerce are crucial for PG as consumer purchasing shifts online, providing opportunities for volume growth through targeted content and personalized recommendations [1][2] - PG's scale, data capabilities, and brand equity position it well to leverage digital channels, enhancing visibility and conversion for core brands while supporting innovation trials [2][3] - Advanced analytics and AI-driven insights enable PG to target consumers more precisely, improving demand forecasting and facilitating faster feedback loops between innovation and execution [3] Group 2: Competitive Landscape - Church & Dwight (CHD) and Colgate-Palmolive (CL) are also utilizing digital retail and e-commerce as growth drivers, capitalizing on changing consumer behaviors to expand reach and support sustained volume growth [4][5] - CHD benefits from its focused brand portfolio and strong power brands, using online channels to efficiently reach targeted segments and support faster trials of new products [5] - Colgate leverages digital platforms to enhance consumer engagement and expand access in emerging markets, particularly in habit-driven categories like oral care [6] Group 3: Financial Performance and Valuation - PG's shares have increased by approximately 2.8% over the past six months, outperforming the industry's growth of 1.5% [7] - PG trades at a forward price-to-earnings ratio of 22.28X, higher than the industry average of 19.88X, indicating a premium valuation [9] - The Zacks Consensus Estimate for PG's fiscal 2026 and 2027 EPS indicates year-over-year growth of 2.2% and 4.7%, respectively, although recent estimates have been revised downward [10][11]

Core Viewpoint - Church & Dwight Company, Inc. (CHD) is set to announce its fourth-quarter fiscal 2025 earnings on January 30, with investors keen to see if the company can exceed market expectations [1] Revenue and Earnings Estimates - The Zacks Consensus Estimate for revenues is $1.64 billion, indicating a 3.5% growth from the previous year [2] - The consensus estimate for earnings has decreased by one cent over the past month to 84 cents per share, suggesting a 9.1% increase year-over-year [2] - CHD has a trailing four-quarter earnings surprise average of 6% [2] Key Factors Influencing Q4 Performance - CHD's fourth-quarter performance is expected to be bolstered by strong momentum in its core brands, driven by effective innovation [3] - The company's diverse portfolio of value and premium products aligns well with current consumer preferences for affordability and high-quality personal care solutions [3] - Brands like Arm & Hammer have achieved record household penetration, particularly in the laundry segment, benefiting from a shift towards value offerings [3] Innovation and Marketing Strategies - The integration of Touchland has surpassed initial expectations, becoming a significant player in the hand sanitizer market [4] - CHD is utilizing its strong innovation pipeline, with new product launches in the Therabreath and Trojan lines anticipated to drive further growth [4] - Increased marketing investments are aimed at sustaining brand consumption and reinforcing competitive positioning [5] Operational Efficiency and Challenges - Productivity initiatives and supply chain strategies have helped mitigate inflation and tariff impacts, supporting profitability while allowing for continued investment in core brands [5] - However, the company is experiencing a decline in sales due to the winding down of discontinued businesses and negative trends in the vitamin and mineral supplement (VMS) sector [6] - The overall operating environment remains challenging due to high promotional activity in certain categories and constrained household finances affecting discretionary spending [6] Earnings Prediction Insights - The current model does not predict a definitive earnings beat for CHD, with an Earnings ESP of -0.81% and a Zacks Rank of 4 (Sell) [7][8]

Core Insights - Church & Dwight Co., Inc. (CHD) has a market cap of $21.1 billion and is recognized for its strong brand portfolio, including ARM & HAMMER, Trojan, and OxiClean, emphasizing innovation and quality [1] - The company is expected to report an adjusted EPS of $0.73 for fiscal Q3 2025, reflecting a 7.6% decrease from $0.79 in the same quarter last year, although it has a history of exceeding Wall Street estimates [2] - For fiscal 2025, analysts forecast an adjusted EPS of $3.46, slightly up from $3.44 in fiscal 2024, with a projected growth of 7.5% year-over-year to $3.72 in fiscal 2026 [3] Stock Performance - Over the past 52 weeks, Church & Dwight shares have declined by 16.3%, underperforming the S&P 500 Index's gain of 16.9% and the Consumer Staples Select Sector SPDR Fund's decline of 3.2% [4] - The stock saw a marginal recovery on August 1 after reporting stronger-than-expected Q2 2025 results, with an adjusted EPS of $0.94 and revenues of $1.51 billion, driven by international sales and e-commerce, which constituted 23% of consumer sales [5] Analyst Ratings - The consensus rating for CHD stock is "Moderate Buy," with 22 analysts covering the stock: nine recommend "Strong Buy," one "Moderate Buy," eight "Hold," and four "Strong Sell." The average price target is $98.44, indicating a potential upside of 14.6% from current levels [6]

Core Viewpoint - Investors are closely monitoring recession indicators following the first federal funds rate cut of the year, with a struggling housing market and labor market warnings suggesting a potential recession, despite rising stock prices [1] Group 1: Church & Dwight (CHD) - Church & Dwight Co. Inc. is recognized for its essential household and personal care brands, which may provide insulation from a potential recession due to their perceived necessity [2][3] - The company has a long history of dividend increases, with a yield of 1.36% and a conservative payout ratio of 55.66%, making it a potential source of stability during volatile periods [3] - CHD shares have declined over 10% year-to-date, attributed to tariff impacts, but analysts predict a recovery with an upside potential of over 14% [4] Group 2: Spire Inc. (SR) - Spire Inc. is a regional natural gas utility firm expanding through the acquisition of Piedmont Natural Gas, which is expected to add over 200,000 customers and contribute to an estimated 8% bottom-line increase in the coming year [5] - The company maintains low operational costs, growing by less than 1% year-to-date, which provides protection against inflation, alongside a dividend yield of 4.08% and a payout ratio of 67.12% [6] Group 3: Chemed Corp. (CHE) - Chemed Corp. operates in home services and healthcare, with its brands Roto-Rooter and Vitas Healthcare providing recession-resistant services [8] - The company faces challenges such as hospice care caps and rising insurance costs, which have pressured CHE shares to their lowest P/E level in over four years, presenting a potential buying opportunity for long-term strength [9]

Core Insights - Church & Dwight Co., Inc. (CHD) has a market capitalization of $22.2 billion and is a leading player in the household, personal care, and specialty products sectors, known for brands like ARM & HAMMER and Trojan [1][2] - The company operates across various segments including domestic, international, and specialty products, serving consumers through retail, e-commerce, and industrial distribution channels [2] Stock Performance - CHD shares have decreased by 21.7% from their 52-week high of $116.46 and have fallen over 6% in the past three months, underperforming the Consumer Staples Select Sector SPDR Fund (XLP), which declined by 1.9% during the same period [3][4] - Year-to-date, CHD stock is down 12.9%, while XLP has returned 1%. Over the past 52 weeks, CHD shares have decreased by 12.3%, compared to XLP's 5.4% drop [4] - The stock has been trading mostly below its 50-day and 200-day moving averages since early April [4] Recent Financial Performance - On August 1, CHD reported stronger-than-expected Q2 2025 results, with adjusted EPS of $0.94 and revenues of $1.51 billion, driven by strong Consumer International sales and e-commerce, which accounted for 23% of consumer sales [5] Competitive Landscape - Rival The Clorox Company (CLX) has underperformed CHD, with CLX stock down 24.4% year-to-date and 26.1% over the past 52 weeks [6] - Despite CHD's recent underperformance, analysts maintain a moderately optimistic outlook, with a consensus rating of "Moderate Buy" and a mean price target of $101.94, representing an 11.7% premium to current levels [6]

Core Insights - The consumer-packaged goods industry features prominent players like Procter & Gamble (PG) and Church & Dwight (CHD), each with unique strategies and brand portfolios [1][2][3] Procter & Gamble (PG) - PG is a leading global company with a diverse product range, maintaining strong market share and customer loyalty despite economic challenges [4][5] - The company employs an integrated growth strategy focusing on product superiority, operational efficiency, and innovation, supported by effective digital marketing [5][7] - PG's supply chain is designed for efficiency and resilience, allowing quick responses to market demands and geopolitical disruptions [6][7] - Financially, PG shows strong free cash flow and consistent capital returns to shareholders, with projected sales growth of 2.6% and earnings growth of 3.6% in fiscal 2026 [13][23] - PG's stock trades at a forward P/E ratio of 22.85, which is lower than CHD's 26.55, indicating a more attractive valuation [18][21] Church & Dwight (CHD) - CHD has demonstrated resilience, gaining volume share in 80% of its business despite macroeconomic pressures, with nine of its 14 major brands outperforming category growth [9][10] - The company focuses on disciplined portfolio management and innovation, recently divesting non-core businesses to concentrate on growth drivers [10][12] - CHD's marketing strategy is aggressive, with a significant portion of net sales allocated to marketing, and it is enhancing its digital presence as online sales grow [11][12] - Financially, CHD's EPS is projected to grow by 1.2% in 2025, while sales are expected to decline by 0.4% [16] - CHD's stock has underperformed compared to PG, with an 8.1% decline over the past year [17][22] Comparative Analysis - PG is positioned as a stronger investment due to its scale, diversified portfolio, and operational excellence, while CHD, despite its agility and niche performance, operates on a smaller scale and faces valuation challenges [22][23]